Clinical Infectious Diseases

The Stercorarian Amplification Advantage: Transmission Biology Determines Xenodiagnostic Sensitivity ✅ Just Accepted 🔗 bit.ly/4cyiodQ

Comparison of ceftolozane-tazobactam and ceftazidime-avibactam in the treatment of MDR/DTR Pseudomonas aeruginosa infections: a systematic review and meta-analysis ✅ Just Accepted 🔗 bit.ly/4tfsk2S

When Switching Antiretroviral Therapy Is Not Enough ✅ Just Accepted #IDTwitter 🔗 bit.ly/4tllSHq

The latest CID supplement issue examines key aspects of tuberculosis (TB), including transmission, disease progression, diagnostic approaches, and treatment strategies. ↪️ bit.ly/3On4jaL

Limited durability of improvements in infection prevention and control practices following reactive interventions leaves healthcare facilities vulnerable to Ebola virus transmission ✅ Just Accepted ✍️ @michaelhawkesmd 🔗 bit.ly/4tcBOMg

A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391) ✅ Just Accepted 🔗 bit.ly/4tJXfEh

2026 Clinical Practice Guideline Update by IDSA and PIDS on The Management of Community-acquired Pneumonia in Infants and Children Older than 3 Months of Age: The Choice of Chest Tube Size ✅ Just Accepted 🔗 bit.ly/4ehciRe

2026 Clinical Practice Guideline Update by IDSA and PIDS on The Management of Community-acquired Pneumonia in Infants and Children Older than 3 Months of Age: The Use of tPa and DNase or tPa Alone for Fibrinolysis ✅ Just Accepted 🔗 bit.ly/4cDFtgb

Long-Term Serologic Outcomes Following Treatment of Syphilis in People With HIV: A Prospective Cohort Study ✅ Just Accepted 🔗 bit.ly/4vmBR9J

2026 Clinical Practice Guideline Update by IDSA and PIDS on The Management of Community-Acquired Pneumonia in Infants and Children Older than 3 Months of Age: The Use of Pleural fluid drainage compared to Surgical Debridement ✅ Just Accepted 🔗 bit.ly/3PKO341

Clinical Practice Guideline by IDSA and PIDS: 2026 Guideline Update on The Management of Community-Acquired Pneumonia in Infants and Children Older than 3 Months of Age ✅ Just Accepted 🔗 bit.ly/4vgm38t

2026 Clinical Practice Guideline Update by IDSA and PIDS on The Management of Community-Acquired Pneumonia in Infants and Children Older than 3 Months of Age: The Use of Chest Ultrasound in Children with Parapneumonic Effusion ✅ Just Accepted 🔗 bit.ly/4sZyp3k

Evaluation of the impact of universal mupirocin decolonization in intensive care units on the utility of MRSA PCR nasal swab testing ✅ Just Accepted 🔗 bit.ly/4bWBN9b

Nasal decolonization and PCR screening in the ICU: friend or foe? ✅ Just Accepted 🔗 bit.ly/4sU5iOF

Antiretroviral Activity, Pharmacokinetics, and Safety of MK-8527, an Oral Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults Living With HIV-1 Who Had Not Previously Taken Antiretroviral Agents ✅ Just Accepted 🔗 bit.ly/3NQNAwy

Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study ✅ Just Accepted 🔗 bit.ly/4vkJ22q

Cephalosporins Versus Non-cephalosporin Antibiotics for Perioperative Prophylaxis in Primary Arthroplasty: A Systematic Review and Meta-Analysis ✅ Just Accepted 🔗 bit.ly/3Qn2Xxm

Estimating Changes in Facility MRSA Infection Rates Due to Changes in MRSA Precaution Policy ✅ Just Accepted 🔗 bit.ly/4bNC78E

When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials ✅ Just Accepted 🔗 bit.ly/4bPWGTk

A Turning Point for Hepatitis C Care: Point-of-Care HCV RNA Authorization as a Critical First Step Towards Integrated Test-and-Treat Models in the United States ✅ Just Accepted 🔗 bit.ly/4sRnp87